vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and Inogen Inc (INGN). Click either name above to swap in a different company.
AMERISAFE INC is the larger business by last-quarter revenue ($80.1M vs $68.6M, roughly 1.2× Inogen Inc). On growth, AMERISAFE INC posted the faster year-over-year revenue change (10.3% vs 3.4%). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs 2.8%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
AMSF vs INGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $68.6M |
| Net Profit | $8.1M | — |
| Gross Margin | — | 51.4% |
| Operating Margin | — | -13.6% |
| Net Margin | 10.2% | — |
| Revenue YoY | 10.3% | 3.4% |
| Net Profit YoY | -9.0% | — |
| EPS (diluted) | $0.43 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | — | ||
| Q4 25 | $81.6M | $68.6M | ||
| Q3 25 | $82.0M | $79.1M | ||
| Q2 25 | $81.1M | $79.2M | ||
| Q1 25 | $72.6M | $68.5M | ||
| Q4 24 | $74.0M | $66.3M | ||
| Q3 24 | $78.7M | $74.9M | ||
| Q2 24 | $75.8M | $74.4M |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $10.4M | — | ||
| Q3 25 | $13.8M | $-5.3M | ||
| Q2 25 | $14.0M | $-4.2M | ||
| Q1 25 | $8.9M | $-6.2M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $14.3M | $-6.0M | ||
| Q2 24 | $11.0M | $-5.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 52.2% | ||
| Q1 25 | — | 53.1% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | — | 55.2% | ||
| Q2 24 | — | 57.4% |
| Q1 26 | — | — | ||
| Q4 25 | 15.6% | -13.6% | ||
| Q3 25 | 21.3% | -9.0% | ||
| Q2 25 | 21.5% | -7.7% | ||
| Q1 25 | 15.5% | -11.2% | ||
| Q4 24 | 22.7% | -17.2% | ||
| Q3 24 | 22.6% | -10.4% | ||
| Q2 24 | 18.1% | -9.5% |
| Q1 26 | 10.2% | — | ||
| Q4 25 | 12.8% | — | ||
| Q3 25 | 16.9% | -6.7% | ||
| Q2 25 | 17.2% | -5.2% | ||
| Q1 25 | 12.3% | -9.0% | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 18.2% | -8.0% | ||
| Q2 24 | 14.5% | -7.5% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.55 | $-0.26 | ||
| Q3 25 | $0.72 | $-0.20 | ||
| Q2 25 | $0.73 | $-0.15 | ||
| Q1 25 | $0.47 | $-0.25 | ||
| Q4 24 | $0.69 | $-0.41 | ||
| Q3 24 | $0.75 | $-0.25 | ||
| Q2 24 | $0.57 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | $103.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.6M | $192.2M |
| Total Assets | — | $298.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | — | ||
| Q4 25 | $61.9M | $103.7M | ||
| Q3 25 | $54.7M | $106.5M | ||
| Q2 25 | $48.5M | $103.7M | ||
| Q1 25 | $44.8M | $118.9M | ||
| Q4 24 | $44.1M | $113.8M | ||
| Q3 24 | $63.7M | $105.7M | ||
| Q2 24 | $30.6M | $97.9M |
| Q1 26 | $246.6M | — | ||
| Q4 25 | $251.6M | $192.2M | ||
| Q3 25 | $274.8M | $197.2M | ||
| Q2 25 | $265.6M | $199.5M | ||
| Q1 25 | $260.8M | $198.0M | ||
| Q4 24 | $257.3M | $173.9M | ||
| Q3 24 | $314.4M | $185.4M | ||
| Q2 24 | $301.0M | $187.6M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $298.6M | ||
| Q3 25 | $1.2B | $307.0M | ||
| Q2 25 | $1.2B | $312.0M | ||
| Q1 25 | $1.2B | $308.4M | ||
| Q4 24 | $1.2B | $296.2M | ||
| Q3 24 | $1.3B | $306.2M | ||
| Q2 24 | $1.2B | $308.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-943.0K |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | $-943.0K | ||
| Q3 25 | $10.7M | $2.2M | ||
| Q2 25 | $-8.4M | $4.3M | ||
| Q1 25 | $-1.8M | $-16.8M | ||
| Q4 24 | $24.2M | $-3.0M | ||
| Q3 24 | $8.4M | $7.0M | ||
| Q2 24 | $-2.6M | $6.7M |
| Q1 26 | — | — | ||
| Q4 25 | $8.9M | $-1.9M | ||
| Q3 25 | $9.8M | $1.6M | ||
| Q2 25 | $-9.5M | $3.7M | ||
| Q1 25 | $-1.8M | $-17.1M | ||
| Q4 24 | $23.4M | $-3.3M | ||
| Q3 24 | $8.4M | $5.3M | ||
| Q2 24 | $-2.6M | $6.6M |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | -2.8% | ||
| Q3 25 | 11.9% | 2.0% | ||
| Q2 25 | -11.7% | 4.6% | ||
| Q1 25 | -2.5% | -24.9% | ||
| Q4 24 | 31.5% | -5.0% | ||
| Q3 24 | 10.7% | 7.1% | ||
| Q2 24 | -3.5% | 8.9% |
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | 1.4% | ||
| Q3 25 | 1.1% | 0.7% | ||
| Q2 25 | 1.3% | 0.9% | ||
| Q1 25 | 0.0% | 0.4% | ||
| Q4 24 | 1.1% | 0.5% | ||
| Q3 24 | 0.0% | 2.2% | ||
| Q2 24 | 0.1% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | — | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | -0.61× | — | ||
| Q1 25 | -0.20× | — | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 0.59× | — | ||
| Q2 24 | -0.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSF
Segment breakdown not available.
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
